Found 1185 matching trials
Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial PHASE3 RATIONALE: Providing information that is tailored to answer patients' quest...
Show More Location
Barbara Ann Karmanos Cancer Institute
Learn More & Join Trial
Re-directed T Cells for the Treatment (FAP)-Positive Malignant Pleural Mesothelioma EARLY_PHASE1 MPM patients are not eligible for surgical procedures like decortication or...
Show More Location
University Hospital Zurich, Division of Oncology
Learn More & Join Trial
Most Closely Human Leukocyte Antigen (HLA)-Matched BK Virus-specific T Lymphocytes (Viralym-B) PHASE1 Patients enrolled on this study will have received a stem cell transplant. ...
Show More Location
Texas Childrens Hospital
Learn More & Join Trial
Autologous T Cells and Cyclophosphamide in Treating Patients With Soft Tissue Sarcoma That is Metastatic or Cannot Be Removed By Surgery PHASE1 This phase I trial studies the side effects and how well giving autologous ...
Show More Location
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Learn More & Join Trial
Recombinant Human Mannose-Binding Lectin (MBL) in Treating Young Patients With MBL Deficiency and Fever and Neutropenia PHASE1 RATIONALE: Recombinant human mannose-binding lectin (MBL) may be effective ...
Show More Location
Children's Hospital of Orange County
Learn More & Join Trial
TACTIC - TAA Specific Cytotoxic T Lymphocytes in Patients With Breast Cancer PHASE2 Status - CLOSED TO PATIENT ENROLLMENT (CNPE)
The study is being conducted ...
Show More Location
Houston Methodist Hospital
Learn More & Join Trial
Clinical Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of LM-108 ยฑ Penpulimab+Chemotherapy in Advanced Solid Tumors - Cohort C PHASE1 This trial is the cohort C part of a multicenter, open label Phase Ib/II cl...
Show More Location
Peking Union Medical College Hospital
Learn More & Join Trial
Autologous CD8+ and CD4+ Transgenic T Cells Expressing High Affinity KRASG12V Mutation-Specific T Cell Receptors (FH-A11KRASG12V-TCR) in Treating Patients With Metastatic Solid Tumor Cancers With KRAS G12V Mutations PHASE1 This phase I trial studies the side effects and best dose of autologous CD8...
Show More Location
Fred Hutch/University of Washington Cancer Consortium
Learn More & Join Trial
Genetically Modified T-cells in Treating Patients With Recurrent or Refractory Malignant Glioma PHASE1 This phase I trial studies the side effects and best dose of genetically mo...
Show More Status
Active Not Recruiting
Location
City of Hope Medical Center
Learn More & Join Trial
Non-specific Response to H1N1 Vaccine N/A This is a prospective observational study with recruitment of healthy volun...
Show More Location
University Clinic of Respiratory and Allergic Diseases
Learn More & Join Trial